Please select a Capability in order to start your service request.
Company Also Celebrates 50 Years of Cannula Production in ColumbusOct 25, 2017
COLUMBUS, Neb., Oct. 25, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to break ground on a $60 million upgrade of its Columbus-East facility.
The 69,000 sq. ft. expansion will transform the Columbus-East facility into the flagship plastic injection molding manufacturing facility for BD, and it will become one of the largest and most sophisticated plastic molding plants in the world. The project is expected to be completed by 2021.
“This is an exciting day for growing the community of Columbus and the State of Nebraska,” said Governor Ricketts. “BD’s $60 million expansion at their Columbus-East facility is another example of how the industry’s faith in our state can help create new opportunities in our communities. With facilities in Columbus, Holdrege, and Broken Bow, BD has been a great partner in growing the Good Life and we appreciate their ongoing investment in Nebraska.”
In addition to Gov. Ricketts, Columbus Mayor Jim Bulkley and Councilman John Lohr also offered words of support for the expansion. Duane Ostdiek, plant manager for the BD Columbus-West facility highlighted the 50th anniversary of cannula (metal part of a needle used in a variety of health care applications) manufacturing at that facility. Bill Campbell, plant manager of the BD Columbus-East facility also was present to commemorate the 15th anniversary of the BD Columbus-East plant.
“BD is one of the largest users of plastic injection molded products in the world, with hundreds of billions of units produced internally each year,” said James Borzi, executive vice president and chief supply chain officer of BD. “The new facility will centralize a majority of BD’s North American plastic molding production and will support multiple business units in the U.S. and around the world.”
Laurie Reagan, the plant manager for the new plastic molding facility, also spoke at the event and highlighted BD’s plans to invest $7 million to retain and retrain its associates for the different skill sets needed for plastic molding manufacturing or to facilitate their transfer to its other manufacturing facility in Columbus or other sites across the BD network. BD is partnering with Central Community College to create customized curriculum for its retraining needs.
In addition to Columbus, BD also has operations in Holdrege and Broken Bow, Neb. and employs approximately 2,500 people across the state. In September 2016, BD announced a $100 million investment in its Holdrege facility to expand its insulin syringe manufacturing operations.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.